Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen Minipigs

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease, which is associated with features of metabolic syndrome. NAFLD may progress in a subset of patients into nonalcoholic steatohepatitis (NASH) with liver injury resulting ultimately in cirrhosis and pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Duvivier, Valérie, Creusot, Stéphanie, Broux, Olivier, Helbert, Aurélie, Lesage, Ludovic, Moreau, Kevin, Lesueur, Nicolas, Gerard, Lindsay, Lemaitre, Karine, Provost, Nicolas, Hubert, Edwige-Ludiwyne, Baltauss, Tania, Brzustowski, Angelique, De Preville, Nathalie, Geronimi, Julia, Adoux, Lucie, Letourneur, Franck, Hammoutene, Adel, Valla, Dominique, Paradis, Valérie, Delerive, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077241/
https://www.ncbi.nlm.nih.gov/pubmed/35535064
http://dx.doi.org/10.1016/j.jceh.2021.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077241/
https://www.ncbi.nlm.nih.gov/pubmed/35535064
http://dx.doi.org/10.1016/j.jceh.2021.09.001

Ejemplares similares